Drug Shortage Report for BIO-IRBESARTAN
| Report ID | 61622 |
| Drug Identification Number | 02446146 |
| Brand name | BIO-IRBESARTAN |
| Common or Proper name | IRBESARTAN |
| Company Name | BIOMED PHARMA |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | IRBESARTAN |
| Strength(s) | 75MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-09-17 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2019-08-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2019-08-21 | French | Compare |
| v6 | 2019-08-21 | English | Compare |
| v5 | 2019-03-21 | French | Compare |
| v4 | 2019-03-21 | English | Compare |
| v3 | 2018-09-18 | English | Compare |
| v2 | 2018-09-17 | French | Compare |
| v1 | 2018-09-17 | English | Compare |
Showing 1 to 7 of 7